comparemela.com

Latest Breaking News On - Immune thrombocytopenic purpura - Page 1 : comparemela.com

Rare Disease Day 2024: Living with Immune Thrombocytopenic Purpura (ITP)

Rare Disease Day 2024: Living with Immune Thrombocytopenic Purpura (ITP)
studentnewspaper.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from studentnewspaper.org Daily Mail and Mail on Sunday newspapers.

Edinburgh
City-of
United-kingdom
Rare-disease-day
Show-your-colour
Immune-thrombocytopenic-purpura
Disease-day
Rare-disease

HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status

— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 —— NDA is supported by data from successful Phase III ESLIM-01 trial in patients with adult primary immune thrombocytopenia who have received at least one previous therapy — .

China
Germany
Spain
Japan
United-kingdom
Hong-kong
France
Italy
Weiguo-su
Stock-exchange-of-hong-kong
Exchange-commission
Practice-research-database

vimarsana © 2020. All Rights Reserved.